Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06369623 · ClinicalTrials.gov registry record · NA

Monetary Incentive Delay Task for Probing Reward-related Neural Processes

A NA study of Adolescent Development, sponsored by Stony Brook University.

Recruiting
Registry status
NA
Development phase
300
Enrollment target
1
Study location

NCT06369623: Recruiting NA study of Adolescent Development, sponsored by Stony Brook University.

NCT06369623 is a NA study of Adolescent Development that is actively recruiting participants, run by Stony Brook University. The registered enrollment target is 300 participants, above the 246-participant average among 8 other Adolescent Development trials with a reported enrollment target (22% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06369623, a NA study of Adolescent Development, is actively recruiting participants, sponsored by Stony Brook University.

RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
1
Study location

Study Summary

150 males and 150 females ages 14-17 years-old will be enrolled in an observational, longitudinal study. There are three planned in-person visits: a baseline assessment, an 18-month follow-up, and a 36-month follow-up. The in-person visits will include assessment of substance use and other individual differences (e.g., reward function, psychiatric history), neuromelanin-sensitive MRI, as well as functional brain activation collected while the participant is at rest (resting-state fMRI) and while the participant completes a Monetary Incentive Delay task. Subjects will also be asked to complete past 90-day substance use assessments remotely every 90 days for 36 months.

Primary Outcome

fMRI activation during task during win, loss, and no change conditions, as well as anticipation and consummation phases.

Conditions Studied

Interventions

  • OTHER Monetary Incentive Delay Task

Study Locations (1)

New York

  • Stony Brook Medicine - Stony Brook

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2024-04-06
Est. Completion 2028-11-30
Phase NA
Stony Brook University

127 total trials

What NCT06369623 shows while recruiting

NCT06369623 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, above the 246-participant average among 8 other Adolescent Development trials with a reported enrollment target (22% higher).

The record links to 1 condition, with Adolescent Development appearing as the primary indexed condition, and to 1 intervention - of which Monetary Incentive Delay Task is the first listed.

NCT06369623 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT06369623 about?

NCT06369623 is a clinical study titled "Monetary Incentive Delay Task for Probing Reward-related Neural Processes". 150 males and 150 females ages 14-17 years-old will be enrolled in an observational, longitudinal study. There are three planned in-person visits: a baseline assessment, an 18-month follow-up, and a 36-month follow-up. The in-person visits will include assessment of substance use and other individua...

What is the current status of trial NCT06369623?

This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2024-04-06. Estimated completion is 2028-11-30.

What conditions does trial NCT06369623 study?

This clinical trial studies the following conditions: Adolescent Development.

What interventions are being tested in trial NCT06369623?

The interventions under investigation include: Monetary Incentive Delay Task (OTHER).

Who is sponsoring clinical trial NCT06369623?

This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06369623 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Adolescent Development

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06369623's enrollment target sits among peer trials

300 3rd of 8 higher than 6 of 8 other Adolescent Development trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Adolescent Development trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06369623, the US trial registry maintained by the National Library of Medicine. NCT06369623 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.